03/26/2024 4:57 PM | Entrada Therapeutics (Issuer) KIM PETER S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/21/2024 3:31 PM | Entrada Therapeutics (Issuer) KIM PETER S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 3:33 PM | Entrada Therapeutics (Issuer) WENTWORTH KORY JAMES (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 6:36 AM | Entrada Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/13/2024 6:24 AM | Entrada Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/13/2024 6:08 AM | Entrada Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/08/2024 3:34 PM | Dowden Nathan J (Reporting) Entrada Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
03/08/2024 3:36 PM | Entrada Therapeutics (Issuer) WENTWORTH KORY JAMES (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 3:22 PM | Entrada Therapeutics (Subject) WENTWORTH KORY JAMES (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024 3:22 PM | Dowden Nathan J (Reporting) Entrada Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024 6:44 PM | Entrada Therapeutics (Issuer) Sethuraman Natarajan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 6:46 PM | Dowden Nathan J (Reporting) Entrada Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 6:47 PM | Entrada Therapeutics (Issuer) WENTWORTH KORY JAMES (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 6:48 PM | Doshi Dipal (Reporting) Entrada Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2024 3:37 PM | Doshi Dipal (Reporting) Entrada Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:19 PM | Doshi Dipal (Reporting) Entrada Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/18/2024 3:32 PM | Doshi Dipal (Reporting) Entrada Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 6:16 AM | Entrada Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/26/2023 3:35 PM | Entrada Therapeutics (Issuer) WENTWORTH KORY JAMES (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/22/2023 3:38 PM | Doshi Dipal (Reporting) Entrada Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/21/2023 3:26 PM | Entrada Therapeutics (Subject) WENTWORTH KORY JAMES (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2023 3:40 PM | Crowley John F (Reporting) Entrada Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/19/2023 4:25 PM | Crowley John F (Reporting) Entrada Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/15/2023 4:24 PM | Crowley John F (Reporting) Entrada Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023 3:38 PM | Crowley John F (Reporting) Entrada Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2023 4:14 PM | Crowley John F (Reporting) Entrada Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2023 6:00 AM | Entrada Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/22/2023 6:35 AM | Entrada Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2023 3:35 PM | Doshi Dipal (Reporting) Entrada Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/07/2023 6:20 AM | Entrada Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023 6:08 AM | Entrada Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/01/2023 6:01 AM | Entrada Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/19/2023 4:27 PM | Doshi Dipal (Reporting) Entrada Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/29/2023 3:35 PM | Entrada Therapeutics (Filer)
| Form 424B5 | |
09/29/2023 3:39 PM | Entrada Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/21/2023 6:09 AM | Entrada Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/15/2023 3:21 PM | Doshi Dipal (Reporting) Entrada Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/06/2023 4:07 PM | Dowden Nathan J (Reporting) Entrada Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/06/2023 4:08 PM | Entrada Therapeutics (Issuer) KREHER NERISSA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/06/2023 4:09 PM | Entrada Therapeutics (Issuer) Sethuraman Natarajan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2023 3:31 PM | Chapman Gina (Reporting) Entrada Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
A lot of people are making this costly mistake (Ad) You may have heard the saying “options are risky” …
And, they can be. But only if you use them the way a lot of folks do.
A lot of people think of BUYING speculative options when they talk about options.
And BUYING low probability, speculative options is definitely risky…
It’s how some folks leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. Click here to jump in on the next one |
08/16/2023 3:32 PM | Doshi Dipal (Reporting) Entrada Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/10/2023 6:09 AM | Entrada Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2023 6:23 AM | Entrada Therapeutics (Filer)
| Form 10-K/A | |
08/08/2023 6:25 AM | Entrada Therapeutics (Filer)
| Form 10-Q/A | |
08/08/2023 6:07 AM | Entrada Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2023 6:14 AM | Entrada Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/01/2023 6:08 AM | Entrada Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/12/2023 3:32 PM | Entrada Therapeutics (Issuer) Sethuraman Natarajan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/12/2023 3:33 PM | Dowden Nathan J (Reporting) Entrada Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/12/2023 3:34 PM | Entrada Therapeutics (Issuer) WENTWORTH KORY JAMES (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/10/2023 3:11 PM | Dowden Nathan J (Reporting) Entrada Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2023 3:12 PM | Entrada Therapeutics (Subject) WENTWORTH KORY JAMES (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/30/2023 3:32 PM | Entrada Therapeutics (Issuer) WENTWORTH KORY JAMES (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:20 PM | Entrada Therapeutics (Issuer) WENTWORTH KORY JAMES (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/22/2023 3:46 PM | Dowden Nathan J (Reporting) Entrada Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/22/2023 3:12 PM | Dowden Nathan J (Reporting) Entrada Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/21/2023 3:18 PM | Entrada Therapeutics (Subject) WENTWORTH KORY JAMES (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2023 3:27 PM | Dowden Nathan J (Reporting) Entrada Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/08/2023 4:11 PM | Entrada Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/10/2023 6:45 AM | Entrada Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/10/2023 6:16 AM | Entrada Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/01/2023 3:38 PM | Doshi Dipal (Reporting) Entrada Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/25/2023 6:00 AM | Entrada Therapeutics (Filer)
| Form DEF 14A | |
04/25/2023 6:01 AM | Entrada Therapeutics (Filer)
| Form DEFA14A | |
04/25/2023 6:03 AM | Entrada Therapeutics (Filer)
| Form ARS | |
04/19/2023 4:50 PM | Entrada Therapeutics (Issuer) Sethuraman Natarajan (Reporting)
| Form 4/A | |
04/19/2023 4:52 PM | Doshi Dipal (Reporting) Entrada Therapeutics (Issuer)
| Form 4/A | |
04/19/2023 5:06 PM | Entrada Therapeutics (Issuer) Sethuraman Natarajan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/19/2023 5:07 PM | Doshi Dipal (Reporting) Entrada Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/19/2023 4:46 PM | Dowden Nathan J (Reporting) Entrada Therapeutics (Issuer)
| Form 4/A | |
04/19/2023 4:48 PM | Entrada Therapeutics (Issuer) KREHER NERISSA (Reporting)
| Form 4/A | |
04/19/2023 4:49 PM | Entrada Therapeutics (Issuer) WENTWORTH KORY JAMES (Reporting)
| Form 4/A | |
04/17/2023 3:46 PM | Entrada Therapeutics (Subject) Sethuraman Natarajan (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2023 4:17 PM | Entrada Therapeutics (Issuer) Zeiher Bernhardt G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2023 6:16 AM | Entrada Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/29/2023 4:12 PM | Doshi Dipal (Reporting) Entrada Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |